These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1031612)

  • 21. [Possibilities and limitations of hypertensive therapy].
    Kaufmann W; Helber A
    Med Welt; 1974 Dec; 25(49):2065-71. PubMed ID: 4444503
    [No Abstract]   [Full Text] [Related]  

  • 22. [Interaction between clonidine and alpha-blockers (author's transl)].
    Huchet AM; Chelly J; Schmitt H
    Nouv Presse Med; 1980 Feb; 9(9):613-4. PubMed ID: 6102376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
    Cagli V
    Clin Ter; 1976 Feb; 76(3):253-60. PubMed ID: 963964
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension.
    Amery A; Verstraete M; Bossaert H; Verstreken G
    Br Med J; 1970 Nov; 4(5732):392-5. PubMed ID: 4921284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of long-term treatment with various antihypertensive drugs on the cardiac mass and on the hemodynamics of patients with essential arterial hypertension].
    Ricciardelli B; De Luca N; Volpe M; Veniero AM; De Simone A; Cuocolo A; Rosiello G; Trimarco B; Condorelli M
    Cardiologia; 1983 Aug; 28(8):679-85. PubMed ID: 6235825
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
    Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
    Klin Med (Mosk); 1984 Mar; 62(3):100-3. PubMed ID: 6716915
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of combination of propranolol and hydralazine versus alpha-methyldopa in hypertension.
    Chopra BK
    J Assoc Physicians India; 1984 Sep; 32(9):811. PubMed ID: 6511772
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prognosis of the effectiveness of hypotensive therapy].
    Zolotaia RD; Zaslavskaia RM; Trubnikov VI; Lil'in ET
    Farmakol Toksikol; 1985; 48(3):66-9. PubMed ID: 4029384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
    Imai Y; Abe K; Otsuka Y; Irokawa N; Yasujima M; Saito K; Sakurai Y; Chiba S; Ito T; Sato M; Haruyama T; Miura Y; Yoshinaga K
    Arzneimittelforschung; 1980; 30(4):674-8. PubMed ID: 6994751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isocarboxazide as an antagonist of the hypotensive effect of alpha-methyldopa].
    Tolva D; Benati E; Colombo G
    Policlinico Prat; 1966 Feb; 73(9):293-9. PubMed ID: 5932989
    [No Abstract]   [Full Text] [Related]  

  • 32. [A comparative study of nisoldipine and alpha-methyldopa in aged patients with isolated systolic hypertension].
    Guillén Llera F; Reuss JM; Sagués F; Tobares N
    Rev Clin Esp; 1991 Dec; 189(9):412-5. PubMed ID: 1792369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of a hypotensive drug, methyldopa].
    François G; Bory M
    Mars Med; 1965; 102(11):911-2. PubMed ID: 5858212
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cicletanine administered with other antihypertensive agents].
    Grimberg D; Tarrade T; Deschamps de Paillette E
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():109-12. PubMed ID: 2575368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive therapy].
    Storm-Mathisen H
    Tidsskr Nor Laegeforen; 1972 Jul; 92(19):1331-7. PubMed ID: 5053651
    [No Abstract]   [Full Text] [Related]  

  • 37. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
    Meine H
    Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study of a new hypotensive drug association].
    Gruppillo P; Tomaini MD
    Clin Ter; 1982 Dec; 103(6):623-33. PubMed ID: 6761046
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.